RECRUITING

Online Interplay Between Deciding and Acting with Mild Cognitive Impairment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators aim to understand the interplay and neural structures involved with decision--making and movement for participants with mild cognitive impairment. Rapidly deciding and acting becomes bottlenecked with mild cognitive impairment and Alzheimer's, leading to detrimental outcomes such as falling and car crashes. The investigators work will have a tangible impact by discovering sensitive biomarkers to detect disease onset and pave the way for informed and effective neurorehabilitation.

Official Title

Online Interplay Between Deciding and Acting with Mild Cognitive Impairment

Quick Facts

Study Start:2025-01-28
Study Completion:2025-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06493422

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:45 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. age 45 - 90 years
  2. 2. Perfect or corrected vision
  3. 3. Ability to reach
  4. 4. Neurotypical Age-Matched control participants - No history of neurological disorders or injury.
  5. 5. Mild Cognitive Impairment participants - clinical diagnosis of amnestic mild cognitive impairment.
  1. 1. Any injury or condition that impacts reaching
  2. 2. Traumatic brain injury, such as concussion, in the last 6 months.
  3. 3. Neurotypical Age-Matched control participants: Modified Telephone Interview for Cognitive Status (TICS-m) score \< 34
  4. 4. Mild Cognitive Impairment participants: Modified Telephone Interview for Cognitive Status (TICS-m) score \> 34
  5. 5. Mild Cognitive Impairment participants: Mini-Mental State Examination Second Edition (MMSE-2) score \< 21.

Contacts and Locations

Study Contact

Joshua Cashaback
CONTACT
(302) 831-2792
joshcash@udel.edu

Principal Investigator

Josh Cashaback
PRINCIPAL_INVESTIGATOR
University of Delaware

Study Locations (Sites)

University of Delaware
Newark, Delaware, 19713
United States

Collaborators and Investigators

Sponsor: University of Delaware

  • Josh Cashaback, PRINCIPAL_INVESTIGATOR, University of Delaware

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-28
Study Completion Date2025-09-30

Study Record Updates

Study Start Date2025-01-28
Study Completion Date2025-09-30

Terms related to this study

Keywords Provided by Researchers

  • Reaching
  • Brain
  • Decisions

Additional Relevant MeSH Terms

  • Mild Cognitive Impairment